Company Financials

Globus Medical, Inc. Financials

United States dollar

business Globus Medical, Inc. Company Profile

Main Stock Listing

NYSE: GMED

Market Capitalization $11.79 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 28.26
Forward PE 21.21
Price to Sales TTM $4.26
Price to Book MRQ $2.67
Enterprise to Revenue 4.12
Enterprise to EBITDA 14.28

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 15.30%
Operating Margin 22.21%
Return on Assets TTM 6.43%
Return on Equity TTM 10.01%

Income Statement

Revenue TTM $2,769,804,032
Revenue per Share TTM $20.40
Quarterly Revenue Growth 22.90%
Gross Profit TTM $1,869,968,000
EBITDA $690,163,000
Net Income to Common TTM $423,779,008
Diluted EPS TTM $3.09
Quarterly Earnings Growth YoY 129.50%

Balance Sheet

Total Cash MRQ $390,523,008
Total Cash per Share MRQ $2.92
Total Debt MRQ $
Total Debt to Equity MRQ 2.73
Current Ratio MRQ 4.13
Book Value per Share MRQ $32.68

Cash Flow

Operating Cash Flow TTM $715,198,976
Levered Free Cash Flow TTM $445,762,752

GMED Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 134,605,452
Float Shares 110,480,216
Avg 10 Volume 1,165,130
Avg 30 Volume None
Shares Short 4,097,040
Short Ratio 2.54
Short % of Shares 4.12%
% Held by Insiders 0.68%
% Held by Institutions 108.67%

Stock Price Summary

Beta 1.07
Fifty Two Week Low $51.79
Fifty Two Week High $94.93
Fifty Two Week Change 3.86%
Day 50 MA $80.10
Day 200 MA $66.36

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date